Membrane-bound TNF induces protective immune responses to M. bovis BCG infection: Regulation of memtnf and TNF receptors comparing two memTNF molecules

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Olleros, Maria L ^a   Vesin, Dominique ^a   Bisig, Ruth ^a   Santiago Raber, Marie Laure ^a   Schuepbach Mallepell, Sonia ^b   Kollias, George ^c   Gaide, Olivier ^b   Garcia, Irene ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; TRANSMEMBRANE TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL LOAD; BONE MARROW; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; DISEASE SEVERITY; GENE TARGETING; HISTOPATHOLOGY; IMMUNE RESPONSE; IN VITRO STUDY; INFECTION RESISTANCE; INFECTION SENSITIVITY; INFLAMMATORY CELL; LUNG TUBERCULOSIS; MACROPHAGE; MICROBIAL IMMUNITY; MORTALITY; MOUSE; NONHUMAN; PROTECTION; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SPLEEN; STRAIN DIFFERENCE; WILD TYPE; ANIMAL; ANIMAL DISEASE; BONE MARROW CELL; C57BL MOUSE; CELL MEMBRANE; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DISEASE RESISTANCE; GENETICS; IMMUNOLOGY; INTRACELLULAR SPACE; METABOLISM; MICROBIOLOGY; MYCOBACTERIUM BOVIS; PATHOGENICITY; SOLUBILITY; TUBERCULOSIS;

BACTERIA (MICROORGANISMS); MUS; MUS MUSCULUS;

ANIMALS; BONE MARROW CELLS; CELL MEMBRANE; CHEMOKINES; DISEASE RESISTANCE; GENE KNOCK-IN TECHNIQUES; INTERFERON-GAMMA; INTRACELLULAR SPACE; MACROPHAGES; MICE; MICE, INBRED C57BL; MYCOBACTERIUM BOVIS; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SOLUBILITY; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84861617153     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031469     Document Type: Article

References (34)

1. Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP, (2008) Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther 117: 244-279.
2. Garcia I, Olleros ML, Quesniaux VF, Jacobs M, Allie N, et al. (2011) Roles of soluble and membrane TNF and related ligands in mycobacterial infections: effects of selective and non-selective TNF inhibitors during infection. Adv Exp Med Biol 691: 187-201.
3. Horiuchi T, Mitoma H, Harashima S, Tsukamoto H, Shimoda T, (2010) Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Rheumatology (Oxford) 49: 1215-1228.
4. Kusters S, Tiegs G, Alexopoulou L, Pasparakis M, Douni E, et al. (1997) In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur J Immunol 27: 2870-2875.
5. Alexopoulou L, Kranidioti K, Xanthoulea S, Denis M, Kotanidou A, et al. (2006) Transmembrane TNF protects mutant mice against intracellular bacterial infections, chronic inflammation and autoimmunity. Eur J Immunol 36: 2768-2780.
6. Ruuls SR, Hoek RM, Ngo VN, McNeil T, Lucian LA, et al. (2001) Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity 15: 533-543.
7. Olleros ML, Vesin D, Fotio AL, Santiago-Raber ML, Tauzin S, et al. (2010) Soluble TNF, but not membrane TNF, is critical in LPS-induced hepatitis. J Hepatol.
8. Torres D, Janot L, Quesniaux VF, Grivennikov SI, Maillet I, et al. (2005) Membrane tumor necrosis factor confers partial protection to Listeria infection. Am J Pathol 167: 1677-1687.
9. Musicki K, Briscoe H, Tran S, Britton WJ, Saunders BM, (2006) Differential requirements for soluble and transmembrane tumor necrosis factor in the immunological control of primary and secondary Listeria monocytogenes infection. Infect Immun 74: 3180-3189.
10. Cowley SC, Goldberg MF, Ho JA, Elkins KL, (2008) The membrane form of tumor necrosis factor is sufficient to mediate partial innate immunity to Francisella tularensis live vaccine strain. J Infect Dis 198: 284-292.
11. Allenbach C, Launois P, Mueller C, Tacchini-Cottier F, (2008) An essential role for transmembrane TNF in the resolution of the inflammatory lesion induced by Leishmania major infection. Eur J Immunol 38: 720-731.
12. Fremond C, Allie N, Dambuza I, Grivennikov SI, Yeremeev V, et al. (2005) Membrane TNF confers protection to acute mycobacterial infection. Respir Res 6: 136.
13. Saunders BM, Tran S, Ruuls S, Sedgwick JD, Briscoe H, et al. (2005) Transmembrane TNF is sufficient to initiate cell migration and granuloma formation and provide acute, but not long-term, control of Mycobacterium tuberculosis infection. J Immunol 174: 4852-4859.
14. Mueller C, Corazza N, Trachsel-Loseth S, Eugster HP, Buhler-Jungo M, et al. (1999) Noncleavable transmembrane mouse tumor necrosis factor-alpha (TNFalpha) mediates effects distinct from those of wild-type TNFalpha in vitro and in vivo. J Biol Chem 274: 38112-38118.
15. Olleros ML, Guler R, Corazza N, Vesin D, Eugster HP, et al. (2002) Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guerin infection in the absence of secreted TNF and lymphotoxin-alpha. J Immunol 168: 3394-3401.
16. Guler R, Olleros ML, Vesin D, Parapanov R, Garcia I, (2005) Differential effects of total and partial neutralization of tumor necrosis factor on cell-mediated immunity to Mycobacterium bovis BCG infection. Infect Immun 73: 3668-3676.
17. Allie N, Alexopoulou L, Quesniaux VJ, Fick L, Kranidioti K, et al. (2008) Protective role of membrane tumour necrosis factor in the host's resistance to mycobacterial infection. Immunology.
18. Dambuza I, Allie N, Fick L, Johnston N, Fremond C, et al. (2008) Efficacy of membrane TNF mediated host resistance is dependent on mycobacterial virulence. Tuberculosis (Edinb) 88: 221-234.
19. Garcia I, Guler R, Vesin D, Olleros ML, Vassalli P, et al. (2000) Lethal Mycobacterium bovis Bacillus Calmette Guerin infection in nitric oxide synthase 2-deficient mice: cell-mediated immunity requires nitric oxide synthase 2. Lab Invest 80: 1385-1397.
20. Eissner G, Kohlhuber F, Grell M, Ueffing M, Scheurich P, et al. (1995) Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. Blood 86: 4184-4193.
21. Perez C, Albert I, DeFay K, Zachariades N, Gooding L, et al. (1990) A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell 63: 251-258.
22. Grell M, Douni E, Wajant H, Lohden M, Clauss M, et al. (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83: 793-802.
23. Decoster E, Vanhaesebroeck B, Vandenabeele P, Grooten J, Fiers W, (1995) Generation and biological characterization of membrane-bound, uncleavable murine tumor necrosis factor. J Biol Chem 270: 18473-18478.
24. Zganiacz A, Santosuosso M, Wang J, Yang T, Chen L, et al. (2004) TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. J Clin Invest 113: 401-413.
25. Olleros ML, Vesin D, Lambou AF, Janssens JP, Ryffel B, et al. (2009) Dominant-Negative Tumor Necrosis Factor Protects from Mycobacterium bovis Bacillus Calmette-Guerin (BCG) and Endotoxin-Induced Liver Injury without Compromising Host Immunity to BCG and Mycobacterium tuberculosis. J Infect Dis.
26. Balcewicz-Sablinska MK, Keane J, Kornfeld H, Remold HG, (1998) Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha. J Immunol 161: 2636-2641.
27. Liu J, Zhao MQ, Xu L, Ramana CV, Declercq W, et al. (2005) Requirement for tumor necrosis factor-receptor 2 in alveolar chemokine expression depends upon the form of the ligand. Am J Respir Cell Mol Biol 33: 463-469.
28. Marino MW, Dunn A, Grail D, Inglese M, Noguchi Y, et al. (1997) Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci U S A 94: 8093-8098.
29. Hanus M, Matouskova M, Verner P, Hyrsl L, (1994) Immunotherapy of superficial bladder tumors: preliminary results with ImmuCyst-BCG Connaught, Toronto. Neoplasma 41: 25-27.
30. Kaps I, Ehrt S, Seeber S, Schnappinger D, Martin C, et al. (2001) Energy transfer between fluorescent proteins using a co-expression system in Mycobacterium smegmatis. Gene 278: 115-124.
31. Olleros ML, Vesin D, Martinez-Soria E, Allenbach C, Tacchini-Cottier F, et al. (2007) Interleukin-12p40 overexpression promotes interleukin-12p70 and interleukin-23 formation but does not affect bacille Calmette-Guerin and Mycobacterium tuberculosis clearance. Immunology 122: 350-361.
32. Guler R, Olleros ML, Vesin D, Parapanov R, Vesin C, et al. (2004) Inhibition of inducible nitric oxide synthase protects against liver injury induced by mycobacterial infection and endotoxins. J Hepatol 41: 773-781.
33. Santiago-Raber ML, Amano H, Amano E, Baudino L, Otani M, et al. (2009) Fcgamma receptor-dependent expansion of a hyperactive monocyte subset in lupus-prone mice. Arthritis Rheum 60: 2408-2417.
34. Fotio AL, Olleros ML, Vesin D, Tauzin S, Bisig R, et al. (2010) In vitro inhibition of lipopolysaccharide and mycobacterium bovis bacillus Calmette Guerin-induced inflammatory cytokines and in vivo protection from D-galactosamine/LPS-mediated liver injury by the medicinal plant Sclerocarya birrea. Int J Immunopathol Pharmacol 23: 61-72.